Suppr超能文献

糖尿病肾病凝血-纤溶系统的研究——参考血浆凝血酶-抗凝血酶复合物及α2纤溶酶抑制物

[Studies on coagulation-fibrinolytic system in diabetic nephropathy--with reference to plasma TAT and alpha 2PIC].

作者信息

Watanabe S, Ogihara T, Iyori S, Kaneshige H, Nomoto Y, Sakai H

机构信息

Department of Internal Medicine, Hiratsuka City Hospital, Kanagawa, Japan.

出版信息

Nihon Jinzo Gakkai Shi. 1990 Sep;32(9):995-9.

PMID:2148199
Abstract

Coagulation-fibrinolytic system is known to be one of the exacerbating factors in patients with diabetic nephropathy. The aim of the present study was to evaluate whether coagulation-fibrinolytic system in patients with diabetic nephropathy were significantly correlated with the development of this disease using new parameters of plasma thrombin antithrombin III complex (TAT) and plasmin alpha 2 plasmin inhibitor complex (alpha 2PIC). Fifty-six patients with NIDDM were examined. None of these patients showed more than 1.3 mg/dl of serum creatinine levels. These patients were divided into three groups according to the levels of albumin creatinine ratio (ACR) in urine as follows: 1) group I had ACR of less than 30 mg/g.Cr; 2) group II had ACR of greater than 30 mg/g.Cr and less than 100 mg/g.Cr; 3) group III had ACR of greater than 100 mg/g.Cr. Correlations of levels of plasma TAT and alpha 2PIC, levels of HbAlc, duration of diabetes, and presence of retinopathy were determined in these groups. The levels of plasma TAT and alpha 2PIC increased as the levels of urinary ACR increased regardless of presence of retinopathy. The levels of TAT and alpha 2PIC with retinopathy increased compared with those without retinopathy. There was a significantly positive correlation between plasma TAT and alpha 2PIC (r = 0.52, p less than 0.01). The levels of HbAlc and duration of diabetes did not significantly correlate to plasma TAT and alpha 2PIC. These data suggest that the existence of increase in coagulation-fibrinolytic system seem to be one of the exacerbating factors in patients with diabetic nephropathy.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

已知凝血-纤溶系统是糖尿病肾病患者病情加重的因素之一。本研究的目的是使用血浆凝血酶抗凝血酶III复合物(TAT)和纤溶酶α2纤溶酶抑制物复合物(α2PIC)的新参数,评估糖尿病肾病患者的凝血-纤溶系统是否与该疾病的发展显著相关。对56例非胰岛素依赖型糖尿病患者进行了检查。这些患者的血清肌酐水平均未超过1.3mg/dl。根据尿白蛋白肌酐比值(ACR)水平将这些患者分为三组:1)第一组ACR小于30mg/g.Cr;2)第二组ACR大于30mg/g.Cr且小于100mg/g.Cr;3)第三组ACR大于100mg/g.Cr。测定了这些组中血浆TAT和α2PIC水平、糖化血红蛋白(HbAlc)水平、糖尿病病程以及视网膜病变的相关性。无论是否存在视网膜病变,血浆TAT和α2PIC水平均随尿ACR水平升高而升高。有视网膜病变的患者TAT和α2PIC水平高于无视网膜病变的患者。血浆TAT和α2PIC之间存在显著正相关(r = 0.52,p < 0.01)。HbAlc水平和糖尿病病程与血浆TAT和α2PIC无显著相关性。这些数据表明,凝血-纤溶系统的增加似乎是糖尿病肾病患者病情加重的因素之一。(摘要截断于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验